과학
기타
FDA approves Simtriyo for treating ADHD in children and adults
Medical Xpress
The U.S.
Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Medical Xpress의 다른 기사
Eosinophilic esophagitis prevalence may be higher than thought in pediatric patients with asthma
Medical Xpress
Combination therapy improves progression-free survival for patients with metastatic dMMR colorectal cancer
Medical Xpress
Researchers call for urgent overhaul of pain care amid opioid crisis
Medical Xpress